Cocrystal Pharma Inc — Quarterly Financial Data (NASDAQ:COCP) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notícias

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

Phillip Frost compra ações da Cocrystal Pharma (COCP) no valor de US$ 18.812

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma conclui oferta direta registrada de US$ 4,7 milhões

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma capta US$ 4,7 milhões em oferta direta registrada

Cocrystal Pharma raises $4.7 million in registered direct offering

Medicamento para norovírus da Cocrystal avança para estudo de fase 1b

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study